Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -8.15% vs 7.09% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -455.15% vs 984.41% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -15.42% vs 20.01% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -64.69% vs 48.70% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Takeda Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -8.15% vs 7.09% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 3.91% vs 0.24% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -455.15% vs 984.41% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -257.34% vs -3,343.49% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -15.42% vs 20.01% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 46.41% vs -8.31% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -64.69% vs 48.70% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -13.26% vs 6.65% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






